Gynecological Cancer

EDU 21 - (INTERACTIVE) Tackling the GYN Tumor Board with a Discussion of Standard and Controversial Cases in Uterine Cancer

9/18/2019
8:00 AM - 9:00 AM
Location: Room W175

Session Type: Education
1.00 AMA PRA Category 1 Credits™
1.00 CAMPEP Credits
1.00 MDCB Credits

This education session will review the management of uterine cancer using a case based tumor board format with special attention to controversial but common clinical scenarios and will include a gynecologic oncologist as well as radiation oncologists to discuss different approaches to management. The clinical impact and need for surgical staging in all uterine cancer patients as well as the recommendation for adjuvant radiotherapy and what volume needs to be treated in those who have positive sentinel nodes or isolated tumor cells without additional nodal evaluation is an open question. The use of adjuvant radiotherapy and chemotherapy also is a source of considerable debate particularly in women with locally advanced uterine cancer. Given the recent data from PORTEC 3 and GOG 258 that have been either published or presented at international meetings, the role of chemoradiotherapy vs chemotherapy alone is particularly controversial. This educational session will review these controversies, and the impact of adjuvant therapy on local control, survival and quality of life will be explored. We will use an interactive audience response system to engage the audience and to understand differences in practice patterns.

Learning Objectives:

Presentations:

ViewAttendees 21 CE Eval

Lilie Lin, MD

MD Anderson Cancer Center

Disclosure:
Employment
MD Anderson Cancer Center: Associate Professor: Employee;
Family: VA Hospital: Radiologist: Employee

Compensation
Astrazeneca: Research Grants: Travel Expenses

Biography:
Dr Lilie Lin is an Associate Professor in the Department of Radiation Oncology at the University of Texas, MD Anderson Cancer Center. Her clinical and research focus is on gynecologic malignancies, in particular she is the principal investigator of multiple clinical trials combining immunotherapy, DNA damage response inhibitors, or radiosensitizers with radiotherapy in gynecologic cancers to improve the therapeutic ratio. She also investigates novel PET tracers and MR sequences to interrogate the tumor microenvironment and understand tumor biology.

Presentation(s):

ViewAttendees 21 CE Eval

Send Email for Lilie Lin


Assets

EDU 21 - (INTERACTIVE) Tackling the GYN Tumor Board with a Discussion of Standard and Controversial Cases in Uterine Cancer



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for EDU 21 - (INTERACTIVE) Tackling the GYN Tumor Board with a Discussion of Standard and Controversial Cases in Uterine Cancer